FDA clears PEM Technologies' breast compression device:
This article was originally published in Clinica
Executive Summary
PEM Technologies has received 510(k) clearance to market its device for applying controlled compression during scintigraphic breast imaging. The device, which is covered by US and international patents, supports, positions and immobilises the breast during examinations involving injectable agents. The Bethesda, Maryland, company, which has developed PET scanners optimised for breast imaging, says that several investigators have shown that unless breast compression is applied, small early cancers can be missed.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.